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SUMMARY 
Radioiodine-labeled human chorionic gonadotrophin (HCG) binds in a highly 
specific manner to sedimentable components from luteinized ovaries of rats in which 
pseudopregnancy has been induced by treatment with pregnant mare's serum gonado- 
tropin and HCG, but not to similar fractions from parotid or adrenal glands. Of the 
other iodinated compounds tested (asialo HCG, oxidized HCG, the ~ and fl subunits 
of H CG and bovine serum albumin) only asialo HCG was bound to a significant 
extent to subcellular fractions from ovarian homogenates. Binding [131i ]HCG to the 
crude 800 × # pellet from ovarian homogenates was inhibited by non-labeled HCG. 
Ovine follicle stimulating hormone, human growth hormone, ovine prolactin, human 
thyroid stimulating hormone and the ~ and fl subunits of HCG were virtually ineffec- 
tive as competitors for HCG binding sites. The possibility that at least a portion of the 
binding to sedimentable components may be due to plasma membrane contamination 
of  the fractions is not excluded. 
The amount of hormone bound to receptor increased with increasing duration 
of incubation, temperature of incubation, and hormone concentration. Kinetic studies 
indicated that the concentration of binding sites is approximately 2 .  10 -14 M and 
that the K d for the radioiodinated hormone was on the order of 10- ' o M. This simple, 
specific, high affinity binding system may provide a tool for investigating initial steps 
in the action of HCG. 
INTRODUCTION 
It is now generally acknowledged that an initial step in the mechanism of 
action of many hormones is their interaction with binding components in target 
tissues. This process has been investigated for steroids 1'2, luteinizing hormone 3, 
Abbreviation: HCG, human chorionic gonadotrophin. 
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insulin*, adrenocorticotropin 5, glucagon 6, and follicle stimulating hormone 7. In our  
previous studies 8 relating to the mechanism of action of human chorionic gonado- 
trophin (HCG), we have shown that components exist in the 800 x # and 110 000 x # 
pellets from luteinized fat ovaries with a marked binding affinity for [ lalI]HCG. The 
maximum activity of the HCG-binding molecule incubated with barbital-HCl buffers 
at 37 °C occurred in the range pH 6.9-7.6. Enzymatic degradation studies indicated 
that the binding component was at least part protein. In this paper we present 
additional data concerning HCG binding. 
METHODS AND MATERIALS 
Immature female rats obtained from the Holtzman Company were injected 
subcutaneously at 10 a.m. on the 24th day of age with 50 I.U. of pregnant mare's 
serum gonadotropin. 56 h after tllis injection, the rats were given 30 I.U. of HCG 
subcutaneously. At 30 days of age a bi-daily regimen of  subcutaneous injections o f  
estradiol benzoate in peanut oil, 10 #g/rat in 0.1 ml, was begun 9. Rats were used after 
they had received at least three injections of estradiol benzoate. This treatment pro- 
duced ovaries that were composed predominately of  luteal tissue. Ovaries and control 
tissues (adrenals and parotids) were removed from these hormonally induced pseudo- 
pregnant rats. The tissues were trimmed of fat and connective tissue and were washed 
in ice-cold phosphate buffered saline [0.01 M phosphateybuffered (pH 7.0) 0.14 M 
NaCI]. The capsules and oviducts were also removed from the ovaries. The tissues 
were homogenized in 4-5 vol. of ice-cold phosphate-buffered saline using an all 
glass Potter-Elvehjem homogenizer. Twenty strokes of the motor-driven pestle were, 
used. The homogenate was dispersed to the desired tissue concentration with phos- 
phate-buffered saline. A single pool of homogenized tissue was used for each experi- 
ment. 
Bindiny assay 
Unless specified, aliquots of homogenate or subcellular fractions were incu- 
bated in the presence of radioiodinated compound in a final volume of  0.5 ml at 37 °C 
for 60 min in a Dubnoff shaker, at 100 oscillations/min. After incubation, 1.5 ml of  
cold phosphate-buffered saline were added to each tube, the tubes were centrifuged 
and the washed pellets were subjected to gamma ray spectroscopy. 
Subcellular fractionation 
The tissues were homogenized in 4 vol. of 0.25 M sucrose and centrifuged at 
800 x # for 10 min. All centrifugations were conducted at 4 °C. The 800 × # pellet was 
resuspended in 2.2 M sucrose containing 1.0 mM Mg 2÷ followed by centrifugation 
for 60 min at 50 000 x #. This step yielded the purified nuclear pellet. The 800 x # 
supernatant was centrifuged at 10 000 x # for 30 rain. The 10 000 × # pellet was resus- 
pended in 0.25 M sucrose and centrifuged for 120 min at 50 000 x y. This step yielded 
the mitochondrial pellet. The 10 000 x y supernatant was centrifuged at 110 000 x y 
for 100 min. The resultant pellet was the microsomal fraction. 
Hormone preparations 
The method of Greenwood et al. 1°, as modified by Midgley 1~ was used tc> 
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iodinate the proteins. The specific activity of the preparations ranged from 120-200 
pCi/pg. Carrier free Na131I in 0.1 M NaOH obtained from New England Nuclear 
Corporation was the source of the 131I. The HCG used for iodination was ob- 
tained from Roussel Corporation, New York, New York and purified in this 
laboratory 1'. The biological potency was 10 000 [.U./mg prior to iodination. As 
determined by bioassay, HCG iodinated in this manner retains approximately 80 % 
of  its biological activity t 1. The other protein hormones used were kindly prepared and 
provided by Dr Leo E. Reichert, Jr. The ~ and fl subunits of HCG were supplied 
through the courtesy of Dr O. P. Bahl; Dr J. Hickman provided the 100 % desialylated 
HCG (asialo HCG). A mol. wt of 25 000 was assumed t0r HCG in all of our calcu- 
lations. 
Protein determination and reagents 
The amount of protein in the tissue samples was determined by the method of 
Lowry et al. lz. Bovine serum albumin was used as standard. All chemicals were of 
reagent grade. 
RESULTS 
Effect of incubation time on binding 
The influence of duration of incubation on binding of labeled HCG was studied 
by incubation of ovarian homogenates with approximately 0.3 ng of [t31I]HCG for 
15 s to 180min at 37 °C. The results that we obtained are shown in Fig. 1. HCG 
binding was clearly time dependent and half-maximal binding occurred after approxi- 
mately 30 min of incubation. Significant binding was detected as early as 5 min of 
incubation and at 90 min the binding began to plateau. It would appear that at 
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Fig. 1. Effect of  incubation time on binding of  I-[CG. Aliquots of  an ovarian homogenate con- 
taining 16.5 mg of  tissue (wet weight) per 0.5 ml were incubated with 0.3 ng of  [1311]HCG for from 
15 s to 180 rain at 37 °C. At the end of  each incubation period 6.0 ml of  phosphate-buffered saline 
were added to the tubes. The tubes were centrifuged at 800 × g and the resulting pellets were counted. 
Each point is the mean of  two observations. 
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Effect of labeled HCG concentration on binding 
The effect of increasing concentration of radioiodinated H CG  on binding was 
studied under a variety of conditions. Fig. 2 depicts the results of an experiment in 
which 0.06-5.0 ng of labeled HCG were incubated with a comparable amount of  
ovarian, adrenal, or parotid homogenates. Over the range studied, the amount of  
labeled HCG bound to ovarian components increased linearly from 30 to 540 pg. 
Less than 40 pg, however, were bound to either adrenal or parotid tissue over the 
entire range of added hormone. These results indicated that the binding molecule 
existed in the target tissue (ovary) and not in the non-target tissues studied (adrenal 
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Fig. 2. The  effect o f  concentrat ion o f  [ t a l l ] H C G  on binding to the 8 0 0 x g  pellet f rom ovar ian ,  
adrenal  and  parot id  homogenates .  Tissue homogena tes  conta in ing 7.0 m g  of  t issue (wet weight) 
per  0.5 ml were incubated  under  the usua l  condi t ions with 0.06-5.0 ng o f  [ Ia l I ]HCG.  The  800 x g 
pellets were obta ined and  counted.  The  mean  ±S .E .  (n = 4) is plotted. 
Fig. 3. Effect o f  incubat ion tempera ture  on binding to the 800 x g pellet f rom ovar ian tissue. 800 x g 
pellets were obta ined f rom an ovar ian homogena te  conta in ing 12 mg  (wet weight) o f  tissue per  
0.5 ml. Labeled H C G  (1.0-7.0 ng) was added to each incubat ion tube. The  incubat ion was carried 
out  at 4 °C for 40 h. W h e n  the incubat ion  was completed,  the  800 x g pellets were ob ta ined  and 
counted .  The  mean  o f  two observat ions  is plotted. 
Effect of temperature of incubation on binding 
We previously demonstrated 8 that of several incubation temperatures investi- 
gated, the greatest amount of HCG binding occurred at 37 °C; after incubation for 
60 min at 0 °C little binding took place. We have examined binding at low tempera- 
tures further. The data presented in Fig. 3 shows that when 1.0-7.0 ng of labeled 
intact HCG were incubated for 40 h at 4 °C, significant binding occurred. We conclude 
from these studies that the binding process does occur at low temperatures, but at a 
considerably reduced rate. This suggested that the formation of the HCG receptor 
complex is not energy dependent, but that it represented an association reaction. 
Determination of an equilibrium constant.for [13 I I]HCG 
To obtain an estimate of the equilibrium constant of dissociation (Kd) for 
radioiodinated HCG, resuspended 800 x g pellets containing approximately 170/~g 
of protein per tube were incubated with 0.5 • 10-9-5.5 • 10 -9 M [131I]HCG at 4 °C 
for 40 h or at 37 °C for 3 h. Double reciprocal plots 13 of the data that we obtained 
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are  shown in Fig. 4. The est imates  computed  f rom the intercepts  o f  the least  squares  
regress ion lines indicate  that  the concen t ra t ion  o f  b inding  sites in the system was 
between 1.54. 10-14 M (4 °C incuba t ion )  and 2 .  10-14 M (37 °C incubat ion) .  The 
K a was between 5 • 10 - 1 °  M (4 °C incuba t ion)  and 6.2 • 10 - t °  M (37 °C incubat ion) .  
Since the number  of  b inding  sites was app rox ima te ly  the same at  bo th  incubat ion  
tempera tures ,  it would  appea r  tha t  li t t le degrada t ion  of  the recep tor  due to pro teo-  
lysis or  o ther  degrada t ive  processes occurred  dur ing  incuba t ion  for  3 h at 37 "C. 
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Fig. 4. De te rm ina t ion  o f  an equ i l ib r ium constant  fo r  [1311]HCG. Washed 800 , :g  pellets f rom an 
ovarian homogenate in which the tissue concentration was 10 mg (wet weight) per 0.5 ml were 
incubated at either 4 °C (a) for 40 h or at 37 °C (b) for 3 h with 0.5 • 10-9--5.5 ' 10 -9 M radioiodi- 
nated FfCG. When the incubations were completed, the 800 × g pellets were sedimented and counted. 
Each point is the mean of three observations. 
Specificity of HCG binding 
To determine  whether  the H C G  molecule  mus t  be in its nat ive state to bind to 
receptor ,  app rox ima te ly  500 pg  o f  [13 I I ] H C G ,  r ad io iod ina t ed  bovine  serum a lbumin,  
H C G  that  had  been oxidized with  hydrogen  peroxide  14 pr io r  to iodina t ion ,  labeled 
des ia ly la ted  H C G ,  and  r ad io iod ina t ed  ~ or  fl subuni ts  o f  H C G  were incubated  wi th  
c o m p a r a b l e  amoun t s  of  ovar ian,  adrenal ,  o r  pa ro t id  homogenates .  Labe led  nat ive 
and  asialo H C G  each appea red  to b ind  equal ly  well to componen t s  f rom ovar ian  
homogena tes ,  whereas the subunits ,  oxidized H C G ,  and bovine serum a lbumin  bound  
a t  a low level in a non-specific manner  to all three tissues (Table  I). 
The abi l i ty  o f  subuni ts  o f  H C G  and  o f  o ther  ho rmones  to compete  with [13ll ]- 
H C G  for  b ind ing  sites on the ovar ian  receptor  present  in the 800 × 9 pellet was exa-  
mined.  0.5 ng o f  r ad io iod ina t ed  H C G  and three concent ra t ions  o f  unlabeled h o r m o n e s  
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TABLE I 
COMPARISON OF BINDING OF ‘=I-LABELED HCG, ASIALO-HCG, OXIDIZED HCG, 
HCG a SUBUNIT, HCG /I SUBUNIT AND BOVINE SERUM ALBUMIN TO THE 800x@ 
PELLET OF OVARIAN, ADRENAL AND PAROTID HOMOGENATES 
Tissue homogenates containing 4.1 mg, wet weight per 0.5 ml, were centrifuged at 800 x g. 0.5 ng of 
i3iI-labeled protein was added to the tubes; the volume was adjusted to 0.5 ml with phosphate-buf- 
fered saline and the resuspended pellets were incubated under the usual conditions for 60 min. 
After the incubation was completed, the pellets were washed and counted. 
Compound added Per cent of total 131 I-labeled protein bound* 






Bovine serum albumin 
10.8kO.7 1.2fO.l l.lkO.1 
9.7*0.1 1.5hO.2 1.1+0.2 
1.210.1 0.8kO.l l.OztO.1 
2.2hO.5 4.3 *to.5 3.3 ho.8 
2.5+0.2 2.2 *0.2 1.5*0.1 
1.2*0.4 1.410.2 1.9*0.1 
* Per cent bound +S.E., n = 4. 
** These data were previously reported*. 
were added to tubes containing resuspended 8OOxg pellets. The data presented in 
Fig. 5 show that 10 ng of non-labeled intact HCG caused approximately an 85 % 
inhibition of binding of labeled HCG and 100 ng of non-labeled intact HCG caused 
complete inhibition of binding. The inhibition caused by human thyroid stimulating 
hormone can be accounted for by the known luteinizing hormone contamination 
(as determined by radioimmunoassay) of the preparation. Ovine follicle stimulating 
hormone, human growth hormone, ovine prolactin and the subunits of HCG produced 
virtually no inhibition. These results show that the receptor is highly specific for HCG 
and that the subunits of the hormone must be associated to compete effectively with 
radioiodinated HCG for binding sites. 
1.0 10.0 1w.tl 1000.0 
ng HORMONE / 0.5 ml 
Fig. 5. 0.5-ml aliquots of an ovarian homogenate in which the tissue concentration was 6.1 mg per 
0.5 ml were centrifuged at 800 x g. The supernatants were decanted and discarded. The resuspended 
800 x g pellets were incubated under the usual conditions with 0.5 ng [i3’I]HCG plus three con- 
centrations of unlabeled competing hormones. The amount of labeled HCG bound in the absence 
of competing hormones was considered 100 %. The mean of 4 observations is plotted. 0 PRO, 
ovine prolactin; 0 FSH, ovine follicle stimulating hormone; HGH, human growth hormone; HTSH, 
human thyroid stimulating hormone; a subunit and /I subunit, the a and /? subunits of HCG. 
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Subcellular localization of the binding molecule 
The subcellular localization of the H C G  receptor was approached in two ways. 
First, the homogenates were centrifuged to isolate operationally defined nuclear, 
mitochondrial, and microsomal fractions. Labeled H C G  was added to aliquots from 
each component;  the fractions were incubated, centrifuged, and the resultant pellets 
were counted. Secondly, homogenates were incubated with labeled HCG,  the sub- 
cellular fractions were then isolated by differential centrifugation, and counted. 
T A B L E  Ii 
B I N D I N G  OF  V A R I O U S  R A D I O I O D I N A T E D  P R O T E I N S  TO S U B C E L L U L A R  F R A C T I O N S  
OF  O V A R I A N  H O M O G E N A T E S  
Luteinized rat ovaries were homogenized  and fract ionated as described. Approximate ly  0.5 ng o f  
311-labeled prote in  was added to tubes conta in ing  either whole homogena te  or subcellular  fractions 
(170 Itg o f  protein  per  0.5 ml). Incubat ion  was carried out  as usual;  the tubes  were centrifuged; and  
the  result ing pellets were counted.  
Fraction PO radioiodinated compound bound/my protein* 
HCG Asialo-HCG ~-Subunit fl-Subunit Bot, ine Oxidized 
Whole  homogena te**  127 ± 6 122 ~ 2 
800 × y  pellet 2 1 3 ± 6  217:k6 
"Nuc le i "  88±1  8 4 ± 4  
Mi tochondr ia  563~-8 5 7 4 ± 9  
Microsomes  363 ± 2  359 ~ 3 
* pg bound  ±S .E . ,  n := 4. 
serum HCG 
albumin 
3 4 ± 3  57±1  7 2 ± 7  74~: 10 
2 1 ± 4  5 9 ± 4  7 2 ± 5  78 ~ 7 
2 6 ± 8  7 3 ± 5  5 2 ± 7  61% 7 
4 0 ~ 4  54:k6 54:•9 48~r 3 
**  The labeled prote in  was added to the whole homogena te .  After  incubat ion,  the 800 ,, y pel- 
let was counted.  
Aliquots equivalent to 170/~g of protein were taken from the whole homoge- 
nate, the 800 × g pellet, the purified nuclear fraction, the mitochondrial fraction, and 
the microsomal fraction. 0.5 ng of [131I]HCG, asialo HCG, bovine serum albumin, 
oxidized HCG, or the c~ or/~ subunits of  H C G  were added to each fraction. The results 
are shown in Table II. While labeled HCG and asialo HCG bound to some extent to 
all of  the fractions, the greatest binding per mg of protein occurred in the mitochon- 
drial and microsomal fractions. The other iodinated proteins bound to a small extent 
in a non-specific manner to all of the fractions. We have yet no definitive evidence 
that H C G  is actually bound to nuclei, mitochondria, or microsomes per se, but it is 
evident that binding material does sediment with these frzctions. Since a 40 o{, reduc- 
tion in the amount  of  [131I]HCG bound occurred when the 800 ~ g pellet was centri- 
fuged through 2.2 M sucrose, one must assume that a large portion of the binding 
that was obtained with the crude 800 × g pellet was to membrane contamination of 
that fraction (Table I1). When we incubated whole ovarian homogenate with radio- 
iodinated H C G  and then isolated the subcellular fractions, a similar pattern of binding 
was obtained as when isolated fractions were incubated with [1311]HCG. These data 
suggest the possibility that intracellular binding sites might exist for either the intact 
H C G  molecule or some portion of it. 
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DISCUSSION 
We have shown that radioiodinated HCG binds in a highly specific manner to 
sedimentable components from luteinized rat ovaries. The binding seems to be related 
to some extent to the biologic activity of the hormone. Oxidized HCG and the sub- 
units of HCG lack biologic activity and, once iodinated, bind to a lesser degree than 
does intact biologically active hormone. Radioiodinated asialo HCG, which has very 
low in vivo biological activity, appears to bind as well as intact hormone. When the 
ability of various unlabeled hormones (HCG, the a and fl subunits of HCG, follicle 
stimulating hormone, thyroid stimulating hormone, growth hormone, and prolactin) 
to inhibit the binding of [131I]HCG to the crude 800 × g pellet from ovarian homoge- 
nates was tested, inhibition was exhibited only by HCG. 
Luteinizing hormone, follicle stimulating hormone, HCG and thyroid stimu- 
lating hormone are composed of two subunits 15-18. One subunit (a) appears to be 
common to all of  these hormones while the other subunit (fl) is the hormone specific 
portion of the molecule. If the fl subunit is the hormone specific portion, the biologic 
activity may reside there. One would presume that physiologic receptors would re- 
cognize and react with the subunit containing the biologically active site, and one 
might expect this subunit to bind as well as intact hormone. This is not what we ob- 
served. In the subunit binding studies, equal masses of labeled HCG and subunits 
were used. The molar concentration of the subunits was, therefore, approximately 
double that of intact hormone. When calculations are made on an equimolar basis 
the fl subunit bound three times better than the ~ subunit, but only 1/5 as well as intact 
hormone to the crude 800 × g pellet. A plausible explanation for the reduced binding 
of  the fl subunit as compared to intact hormone is that certain interactions must occur 
between the subunits to effect the proper molecular configuration or charge field 
to produce full binding activity. It is of interest to note that Yang et al.19 have shown 
the fl subunit of  luteinizing hormone is capable of inducing ovulation, but that four 
times more of the subunit than of the native hormone is required. They report that 
the a subunit is inactive. Kammerman and Canfield z o have reported that the fl subunit 
is more potent than the a subunit in inhibiting the in vivo uptake of HCG. It is possible 
that the individual subunits may either possess some residual binding activity or that 
they may contain trace contamination with intact hormone or both. 
Dufau et al. 2° have reported that their preparations of asialo HCG were at 
least as effective as intact HCG in inhibiting binding of [125I]HCG to receptors in rat 
testes and ovaries in vitro. Kammerman and Canfield 21 have reported that asialo H CG  
is less effective than intact HCG in blocking [~25I]HCG uptake by mouse ovary 
in vivo; they propose that this is due to the recognized differences in the plasma half- 
life of the two molecules 22. It has also been shown 23 that, at low concentrations, 
desialylated HCG possesses about 25-50 % of the ability of the native hormone to 
promote testosterone synthesis. This observation is in good agreement with our fin- 
dings that asialo HCG seems to be approximately 15 % as effective as intact HCG in 
activating ovarian adenylate cyclase z4. Since we find that radioiodinated HCG and 
asialo HCG both bind to the ovarian receptor to the same extent, explanations for the 
apparent dichotomy between binding and biological activity (in the case of the ovary, 
adenylate cyclase activation) must be sought. 
It is possible that processes other than the effects of desialylation on the half- 
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life of  the H C G  molecule need be invoked to account for the decreased in vitro 
"biologic potency" of asialo H C G  that has been observed by Dufau and co-workers 
and by us. There is evidence that adenylate cyclase is composed of two units: a discri- 
minator  region and a catalytic region 25. The hypothesis is that the discriminator is 
capable of recognizing and combining with a specific hormone. This interaction is 
subsequently translated into activation of the catalytic subunit. The observations 
that two forms of a hormone bind to the same extent, but give rise to a dramatically 
different degree of "biologic response" may be a manifestation of this or an analogous 
phenomenon. Since H C G  and asialo H C G  bind equally well to ovarian and testicular 
receptors, it would appear that the next reaction, the "information transfer" process, 
is achieved more readily by the intact H C G  molecule than by its desialylated analog. 
We have obtained a Kd on the order of 10-i  o M for the H C G  receptor in the 
800 x g pellet. Since this value was obtained with iodinated hormone, the exact degree 
of damage and the biological activity of  which we did not assess, this must be consi- 
dered only an estimate of  the Kd for intact non-labeled hormone. One recognizes that 
if a binding substance is to qualify as a physiological receptor, it must have a K d 
such that is effective at blood levels of the hormone. Since H C G  is not normally 
present in rat blood, a direct comparison cannot be made. It is known, however, that 
the minimal effective dose of H C G  in immature rats is approximately 0.01 I.U., 
which is approximately 10 ng of "pure"  hormone if "pure"  hormone is considered 
to be 10 000 I.U./mg. Assuming a 3.0-ml blood volume, this is equivalent to a hor- 
mone concentration of 1.1 • 10-l0 M. The maximum effective dose is approximately 
50 I.U., yielding a blood concentration of 5" 10 -8 M. The Ko that we have obtained 
(5.  10-1 o_6. 2 . 10-lo M) would provide a high degree of sensitivity over the effec- 
tive dose range. 
It is widely assumed 26-29,6 that the primary interaction of polypeptide hor- 
mones is with the cell membrane. Our studies cannot exclude the possibility that all 
of the binding that we observe is to plasma membranes since we did not examine our 
subcellular fractions for the presence of membrane associated enzymes nor did we 
examine them by electron microscopy for membrane contamination. It would appear 
that much of the binding that we obtain in the 800 × 9 pellet is to membranes since 
when this pellet was centrifuged through 2.2 M sucrose, thus eliminating a considerable 
amount  of  membrane contamination, much of the binding activity was lost. The H C G  
binding that we have obtained to components sedimenting with mitochondria and 
microsomes may indicate plasma membrane contamination of these fractions or it 
may indicate that there are intracellular "binders" for the hormone. Such binders may 
be involved in steroidogenesis, in the "trophic" effects of the hormone, and/or in 
hormone metabolism. 
The existence of a specific receptor(s) for H C G  in luteinized ovaries will provide 
a tool for investigating the metabolism of the hormone as well as for determining the 
portion of the molecule that is necessary for its biologic action. The existence of the 
receptor will also permit a detailed investigation of the initiation of the biochemical 
events leading to its mechanism of action. 
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